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mice than wild-type controls at 7 and 10 days postinjury; however, contrary to our original hypothesis, no difference in force-producing capacity of the TA muscle was evident between the two groups at either time point. Our findings reveal that nNOS is not essential for functional muscle regeneration after acute myotoxic damage. skeletal muscle injury; muscle repair; neuronal nitric oxide synthase; contraction; fatigue SKELETAL MUSCLES ARE SUSCEPTIBLE to damage from trauma, metabolic deficits, disease, and mechanical strains during lengthening (eccentric) contractions (4, 5, 20, 21) . Although skeletal muscles have an impressive capacity to regenerate after injury, the repair is often slow and sometimes incomplete (11) . Because the loss of muscle function can impact significantly on the lives of those affected, there is a need to better understand the process of skeletal muscle regeneration to develop novel strategies and treatments that can promote muscle function after injury and improve quality of life for patients (29) .
Nitric oxide (NO) is an important signaling molecule that plays a critical role in a number of biological processes. NO is synthesized from L-arginine by NO synthase (NOS) enzymes, of which three isoforms have been characterized: two "constitutive" isoforms [neuronal NOS (nNOS)/NOS1 and endothelial NOS (eNOS)/NOS3] and an "inducible" isoform (iNOS/ NOS2). The primary isoform of NOS in skeletal muscle is the muscle-specific splice variant nNOS (32) , although skeletal muscle also expresses some eNOS and, particularly during muscle inflammation, iNOS. The functional role of NO in skeletal muscle is complex. NO has been implicated in a number of aspects of muscle function, such as contractility (7, 23) , Ca 2ϩ homeostasis (26) , and muscle regeneration in conditions such as muscular dystrophy (2, 34) . Previous studies examining the role of NO in regeneration from acute muscle injury have found that inhibition of NO production by all NOS isoforms with nitro-L-arginine methyl ester (L-NAME) inhibits successful muscle regeneration (1, 8, 9) , although the contribution of nNOS-derived NO to this phenomenon is less clear. Furthermore, none of the studies on the role of NO in regeneration after acute injury examined arguably the most important facet of muscle regeneration, the restoration of muscle force-producing capacity.
The present study sought to address this gap in existing knowledge by examining the functional regeneration of muscles in nNOS null (nNOS Ϫ/Ϫ ) mice after acute injury. We hypothesized that nNOS Ϫ/Ϫ mice would exhibit impaired muscle fiber regeneration after myotoxic injury, as evidenced by impaired muscle function and associated morphological changes, compared with wild-type littermates.
MATERIALS AND METHODS
Animals. All procedures were approved by the Animal Ethics Committee of The University of Melbourne and conformed to the Australian code of practice for the care and use of animals for scientific purposes as stipulated by the National Health and Medical Research Council (Australia). Mice homozygous for targeted disruption of the nNOS gene (B6129-NOS1 tm1plh , nNOS Ϫ/Ϫ ) (12) were purchased from Jackson Laboratories (stock no. 002633, Bar Harbor, ME). A colony was then established by backcrossing the nNOS Ϫ/Ϫ mice onto a C57BL/6 background for at least six generations to obtain a colony of nNOS Ϫ/Ϫ mice and wild-type littermate controls, with genotyping performed from tail clippings taken at day 21. Mice were housed in the Biological Research Facility at The University of Melbourne under a 12:12-h light-dark cycle, with drinking water and standard chow provided ad libitum. Male mice [20 nNOS Ϫ/Ϫ and 24 nNOS ϩ/ϩ (wild-type) littermates] were used at 8 -9 wk of age. Myotoxic injury. Myotoxic injury was induced in the tibialis anterior (TA) muscles of mice as described previously (31) . Briefly, mice were anesthetized with a mixture of ketamine (76 mg/kg ip) and xylazine (10 mg/kg ip), and a small portion of the TA muscle of the right hindlimb was surgically exposed by a single incision through the skin. The muscle was filled to its maximal holding capacity (ϳ40 l) via a single intramuscular injection with the myotoxin notexin (1 g/ml; Latoxan) using a 29-gauge needle. The wound was closed with Michel clips (Aesculap, Tuttlingen, Germany), and the mice were allowed to recover from the myotoxic injury for 7 or 10 days before assessments of muscle structure and function.
Muscle function. Mice were anesthetized with pentobarbital sodium (60 mg/kg ip), and TA muscle function was assessed in situ as described previously (10) . Briefly, TA muscles were stimulated by supramaximal 0.2-ms square-wave pulses of 350-ms duration, delivered via two wire electrodes adjacent to the sciatic nerve. Optimal muscle length for contraction was defined as the muscle length at which maximal isometric twitch force (P t) was attained, and the absolute maximal isometric tetanic force (Po) was determined from the plateau of the frequency-force relationship. Measurements of Po were normalized to the cross-sectional area (CSA) of the muscle (calculated using optimal muscle length and muscle mass) to determine maximum specific force (sP o), a measurement that allows for relative comparisons of force production between muscles of different sizes. Immediately following the functional assessments, the muscles were carefully excised, trimmed of any adherent nonmuscle tissue and tendons, and weighed. Muscles were then mounted in Tissue-Tek OCT embedding medium, frozen rapidly in thawing isopentane, and stored at Ϫ80°C for later histological and biochemical analyses. The mice were killed by surgical excision of the heart while they were still anesthetized deeply.
Immunohistology. Transverse sections (5 m) were cut from the midbelly of each muscle on a cryostat microtome, and serial sections were placed onto glass slides (Superfrost Plus, Menzel-Gläser, Kensington, VIC, Australia). General muscle histology was determined by staining sections with hematoxylin and eosin for visualization of muscle fibers and areas of inflammatory cell infiltration after myotoxic damage. Fiber CSA and central nucleation (a distinguishing feature of regenerating muscle fibers) were determined immunohistochemically by probing for the membrane protein laminin and nuclei using a polyclonal ␣-laminin primary antibody (Sigma-Aldrich, Castle Hill, NSW, Australia) and 4=6-diamidino-2-phenylindole (Invitrogen, Mulgrave, VIC, Australia) as described previously (15) . Macrophages were visualized after sections were reacted with an F4/80 antibody (Ab 60343, Abcam, Sapphire Bioscience, Waterloo, NSW, Australia). The percentage of type IIa fibers in the TA muscle was determined by probing sections with the antibody N2.261 (Developmental Studies Hybridoma Bank, The University of Iowa), and capillaries were visualized using ␣-CD31 antibody (Abcam). Digital images of stained sections were obtained using a fluorescence microscope and camera (Carl Zeiss, Wrek, Göttingen, Germany) with associated imaging software (Axiovision version 4.7.1.0). CSA and central nucleation were determined for Ն500 individual fibers from each section from Ն4 muscles per experimental group.
Oxidative enzyme activity was determined from reacting sections for succinate dehydrogenase (SDH) activity as described previously (3) . Optical density of the SDH reaction product was determined after 6 min for all samples and sections captured in full color using bright-field light microscopy. The images of SDH reactivity were converted to grayscale values, and the mean optical density of all pixels in a given myofiber was determined and then corrected for the mean optical density in a field of view containing no myofibers (14) .
Determination of blood flow during fatigue. Changes in blood flow in the TA muscle during the fatiguing stimulation protocol were determined by infrared laser-Doppler assessment using a moor-FLPI full-field blood perfusion imaging system (Moor Instruments, Devon, UK). The subsurface vessels of the exposed TA muscle were imaged before stimulation and again immediately after completion of the fatigue protocol. Blood flow (flux) was measured in arbitrary units by the associated moorFLPI software (Moor Instruments).
Quantitative RT-PCR. Muscle samples were homogenized individually, and mRNA was extracted using an RNeasy fibrous tissue RNA extraction kit (Qiagen, Doncaster, VIC, Australia) according to the manufacturer's instructions. The concentration and quality of RNA in each sample were determined using a Nanodrop 2000 (Thermo Fisher Scientific, Scoresby, VIC, Australia), and the extracted mRNA was stored at Ϫ80°C. mRNA was transcribed into cDNA using the Superscript VILO cDNA synthesis kit (Invitrogen) according to the manufacturer's instructions and stored at Ϫ20°C until further analysis. Quantitative RT-PCR was performed using an iCycler Thermal Cycler (Bio-Rad) with SYBR Green supermix (Quantace, Bioline, Alexandria, NSW, Australia). Primers for myosin heavy chain (MyHC) I, MyHC IIa, MyHC IIx, MyHC IIb, cyclooxygenase (COX) IV, calcineurin, and peroxisome proliferator-activated receptor-␥ co- Table 1 .
Real-time RT-PCR primers
nNOS and eNOS, neuronal and endothelial nitric oxide synthase; SOD1, Cu 2ϩ ,Zn 2ϩ superoxide dismutase; PRDX6, peroxiredoxin 6; Hsp70, heat shock protein 70.
activator 1␣ (PGC-1␣) have been published previously (22) . Primers for nNOS, eNOS, myogenin, catalase, Cu 2ϩ ,Zn 2ϩ -SOD, peroxiredoxin 6, and heat shock protein 70 were designed using the Perfect Primer online program (Invitrogen) and are listed in Table 1 . Because of the severity of the myotoxic injury caused by notexin (25), we chose not to use the cycle threshold (⌬C t) method of analysis of mRNA expression, as we could not be certain that the expression of any reference gene used would remain unchanged. We opted, instead, to measure the cDNA concentration of each sample using the Quant-iT OliGreen ssDNA Assay Kit (Molecular Probes, Eugene, OR) and to normalize the data to cDNA content as described previously (19, 22) .
Western blot analysis. Western blot analysis was performed as described previously (22) . Briefly, muscle samples (20 -30 mg) were homogenized in buffer of the following composition: 10 mM Tris·HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 10% glycerol, 1% Triton X-100, 0.1% SDS, 1 mM NaF, 20 mM Na 4P2O7, 2 mM Na3VO4, 0.5% sodium deoxycholate, 1 mM PMSF, 0.1% protease inhibitor cocktail (Sigma Aldrich, Castle Hill, NSW, Australia), and 0.1% phosphatase inhibitor cocktail (Sigma Aldrich). Samples were centrifuged at 10,000 g for 10 min at 4°C, and the resulting supernatant was analyzed for total protein content, heated at 95°C for 5 min with protein loading buffer [40% glycerol, 6% SDS, 250 mM Tris·HCl (pH 6.8), 0.04% bromophenol blue, and 415 nM DTT], and then size-fractionated by SDS-PAGE. Blots were transferred to a polyvinylidene difluoride membrane in standard transfer buffer for 18 h at 4°C and 100 mA and then blocked in Tris-buffered saline-Tween 20 containing 5% skim milk powder or 5% BSA for 2 h at 25°C. After they were blocked, the membranes were incubated with anti-calcineurin (1:1,000 dilution; Abcam), anti-COX IV (1:5,000 dilution; Cell Signaling Technology, Genesearch, Arundel, Queensland), or anti-GAPDH (1:10,000 dilution; Sigma Aldrich) for 2 h at 25°C or anti-PGC-1␣ (1:4,000 dilution; Abcam) overnight at 4°C. The membranes were then washed, incubated with secondary antibody (antirabbit IgG conjugated to horseradish peroxidase; Amersham Biosciences, GE Healthcare Life Sciences), and visualized using enhanced chemiluminescence (ECL plus, Amersham Biosciences). The signal was imaged using a ChemiDoc XRS machine (Bio-Rad, Gladesville, NSW, Australia), and blots were quantified using Quantity One software (Bio-Rad) and normalized against GAPDH protein expression.
Statistical analyses. All values, except those for myofiber CSA, are expressed as means Ϯ SE. Groups were compared using an unpaired Student's t-test or a 2-way ANOVA and Bonferroni's post hoc multiple comparison procedure where appropriate. Because myofiber CSA is not normally distributed, medians were compared using a nonparametric Mann-Whitney test by ranks (for 2 groups) or a nonparametric Kruskal-Wallis ANOVA by ranks (for Ͼ2 groups). All statistical analyses were performed using Prism version 3 software (GraphPad Software). In all cases, significance was defined as P Ͻ 0.05. Fig. 1 . Representative images of tibialis anterior (TA) muscle cross sections from wild-type (WT) and neuronal nitric oxide synthase (NOS)-null (nNOS Ϫ/Ϫ ) mice at 7 or 10 days after myotoxic injury, stained for hematoxylin and eosin (H&E, ϫ20) and reacted for F4/80 antibody (ϫ20) for visualization of macrophages (arrows). While there were occasional pockets of greater inflammatory cell activity in some muscle sections from nNOS Ϫ/Ϫ mice (e.g., bottom, far right), these minor histological variations did not translate to differences in muscle function.
RESULTS

Morphological and isometric contractile properties of uninjured muscles.
We found that the mass of the TA muscle was significantly lower in nNOS Ϫ/Ϫ than nNOS ϩ/ϩ mice (Table 2 ), but since body mass was also lower in these mice (26.5 Ϯ 1.1 vs. 30.3 Ϯ 1.1 g), there was no significant difference in muscle mass relative to body mass (1.73 Ϯ 0.12 vs. 1.79 Ϯ 0.08 mg/g). Representative images of TA muscle cross sections from WT and nNOS Ϫ/Ϫ mice at 7 or 10 days after myotoxic injury, stained for hematoxylin and eosin (ϫ20) and reacted for F4/80 antibody (ϫ20) to visualize macrophages, are presented in Fig. 1 . Histological examination of myofiber CSA in TA muscles from both strains revealed a leftward shift in the frequency distribution of myofiber CSA in nNOS Ϫ/Ϫ compared with nNOS ϩ/ϩ mice and significantly lower median CSA of myofibers from nNOS Ϫ/Ϫ than nNOS ϩ/ϩ mice (Fig. 2, A and B) . In uninjured muscles, P t and twitch half-relaxation time were significantly lower in nNOS Ϫ/Ϫ than nNOS ϩ/ϩ mice, but neither time to peak twitch tension nor rate of twitch force development was significantly different between the two strains ( Table 2) . Absolute P o was also significantly lower in muscles from nNOS Ϫ/Ϫ than nNOS ϩ/ϩ mice (Fig. 2C ), but sP o was not significantly different between the two strains (Fig. 2D) .
Uninjured TA muscles from nNOS Ϫ/Ϫ mice were more resistant to fatigue and recovered from a fatiguing stimulation protocol more quickly than muscles from nNOS ϩ/ϩ mice (Fig.  2E) . Analysis of MyHC mRNA expression revealed that the TA muscles of nNOS Ϫ/Ϫ mice had significantly higher expression of MyHC type I (Fig. 3A) but did not have altered expression of MyHC type IIa, IIx, or IIb compared with nNOS ϩ/ϩ mice (Fig. 3B) . Furthermore, protein expression of the oxidative markers COX IV, calcineurin, and PGC-1␣ did not differ between the two groups of mice (Fig. 3, C and D) . and WT mice. B: median CSA of myofibers. Data were pooled from Ͼ2,000 fibers from Ն4 mice. *Significantly lower than WT (P Ͻ 0.05, Mann-Whitney test by ranks). C: absolute tetanic force production (Po) in TA muscles (n ϭ 8). *Significantly lower than WT (P Ͻ 0.05, t-test). D: tetanic force production measured as force normalized to muscle CSA (sPo) (n ϭ 8). E: fatigability of uninjured TA muscles from nNOS Ϫ/Ϫ and WT mice (n ϭ 8). *KO significantly more resistant to fatigue than WT (strain main effect: P Ͻ 0.05, 2-way ANOVA).
Finally, myofiber SDH activity did not differ between the TA muscles from the two groups (Fig. 3E) .
We then examined the hemodynamic properties of TA muscles from both strains. Immunohistological examination of uninjured muscles revealed no significant differences between nNOS Ϫ/Ϫ and nNOS ϩ/ϩ mice in the number of capillaries per myofiber (Fig. 4A ) or in the number of capillaries per unit area (data not shown). Laser-Doppler assessment of blood flow in the TA muscles before and after the fatigue protocol demonstrated increased blood flow in nNOS Ϫ/Ϫ and nNOS ϩ/ϩ mice after the contraction protocol but no significant difference in the exercise-induced increase in blood flow between the two strains (Fig. 4B) .
We also examined the mRNA expression of selected antioxidant and stress enzymes within the muscles. We confirmed that nNOS mRNA was not present in muscles from the nNOS Ϫ/Ϫ mice but found no significant differences in the mRNA expression of eNOS, catalase, Cu 2ϩ ,Zn 2ϩ -SOD, peroxiredoxin 6, or heat shock protein 70 between muscles from the two strains (Fig. 4C) .
Muscle regeneration after myotoxic injury. We next examined muscle regeneration by subjecting the TA muscles of nNOS ϩ/ϩ and nNOS Ϫ/Ϫ mice to myotoxic injury with notexin. Analysis of myofiber CSA in regenerating muscles from both strains revealed a leftward shift in the frequency distribution of fibers from nNOS Ϫ/Ϫ compared with nNOS ϩ/ϩ mice at 7 and 10 days postinjury (Fig. 5, A and C) and significantly lower median CSA of myofibers from nNOS Ϫ/Ϫ than nNOS ϩ/ϩ mice (Fig. 5B) . However, there was no significant difference in the percentage of centrally nucleated fibers between the two strains at any time point (Fig. 5D) , nor was there any significant difference in myogenin mRNA expression between the two strains at 10 days postinjury (Fig. 5D) .
Finally, we assessed the force-producing ability of the regenerating muscles. We found no difference in P o between nNOS Ϫ/Ϫ and nNOS ϩ/ϩ mice at 7 or 10 days postinjury (Fig. 6A) . Furthermore, there was no significant difference in sP o between strains at 7 or 10 days postinjury (Fig. 6B) .
DISCUSSION
The important role of NO in muscle repair has been the subject of a number of interesting studies (1, 2, 8, 27, 34) . While the importance of NO production in the regenerative process after acute injury has been characterized, the relative contribution of the three isoforms of NOS expressed in skeletal muscle remains unclear. Many previous studies examining the role of NO in regeneration have relied on pharmacological inhibition of NO production by L-NAME; however, because L-NAME inhibits all three NOS isoforms, its use for determining the relative contributions of each is limited. Although the primary isoform of NOS in skeletal muscle is nNOS (32), a specific pharmacological inhibitor of nNOS has yet to be developed, and the best available model for examining the contribution of nNOS to muscle regeneration is the nNOS knockout (nNOS Ϫ/Ϫ ) mouse. Many studies have used this mouse model to examine the role of muscle nNOS in chronic degenerative conditions such as muscular dystrophy (2, 17, 18, 30, 33, 34 ), but only a few studies have examined the role of nNOS in muscle regeneration after acute myotoxic injury (1, 8, 9) , and none have assessed arguably the most important facet of functional muscle regeneration, the return of the muscle's force-producing capacity. To our knowledge, the present study represents the first assessment of the effect of genetic deletion of nNOS on the force-producing capacity of a muscle during regeneration after acute injury using the nNOS Ϫ/Ϫ mouse model.
We first characterized the morphological and contractile properties of the TA muscles of our nNOS Ϫ/Ϫ mice. Percival and colleagues (23, 24) examined the in vitro contractile characteristics of nNOS Ϫ/Ϫ mice and found them to have lower body mass, lower muscle mass, and smaller myofiber CSA and to produce lower absolute P o than muscles from littermate controls, although sP o was identical between the strains. Our contractile data agree with those of Percival and colleagues and confirm that the muscles of nNOS Ϫ/Ϫ mice do not exhibit significantly different contractile characteristics after accounting for differences in muscle size. We were surprised, however, to find that the TA muscles from our nNOS Ϫ/Ϫ mice were more resistant to an in situ fatiguing stimulation protocol than muscles from their littermate controls, in contrast with the earlier study by Percival and colleagues where the muscles of nNOS Ϫ/Ϫ mice were found to be less resistant to fatigue than wild-type littermates (23) . Interestingly, when Percival and colleagues repeated their fatigue protocol on nNOS Ϫ/Ϫ mice in the later study (24) , they no longer observed the difference in muscle fatigability, and they postulated that this was due to the intervening backcrossing of the nNOS Ϫ/Ϫ mice onto a C57BL/6 background, rather than the B6129 background of their first study. Because the mice in our study were also backcrossed onto a C57BL/6 background, our data are more appropriately compared with the data from the later study of Percival and colleagues (24) .
In an effort to determine why our nNOS Ϫ/Ϫ mice were less susceptible to fatigue than the wild-type littermates, we examined the expression of MyHC subtypes and the oxidative capacity of the muscles. We found no difference in the mRNA expression of MyHC type IIa or IIb between nNOS Ϫ/Ϫ mice and wild-type littermates, but the expression of MyHC type I was increased significantly (albeit from a very low level in the predominantly fast-fiber TA muscle). There was a (nonsignificant) trend for increased expression of the more fatigueresistant MyHC type IIx. When muscle oxidative capacity was assessed, we found no differences in protein expression of COX VI, calcineurin, or PGC-1␣, nor did we find any differ- ence in SDH activity between TA muscles from the two groups.
We then examined the hemodynamic properties of the muscle. Previous studies have suggested that a lack of nNOS enhances "functional ischemia" of skeletal muscle (33) and increases fatigue after exercise (13) . We found no differences in capillary density or blood flow between the muscles from nNOS Ϫ/Ϫ and wild-type littermates after a fatiguing protocol. However, our blood flow measurements were determined by laser-Doppler surface imaging of the exposed, but otherwise intact, TA muscle, an assessment of a single muscle and limited only to the blood flow through surface vessels due to the limited penetration of the infrared laser. In contrast, Thomas et al. (33) measured blood flow through the exposed femoral artery, thereby obtaining an estimation of blood flow through all vessels of all muscles of the lower leg. Although we were aware of the limitations of our technique, we chose this method so that we could assess blood flow noninvasively during the fatigue protocol without compromising muscle function. It is possible therefore that further studies examining whole tissue blood flow via Doppler assessment of the femoral artery (33), injection of labeled microspheres (16), or contrastenhanced ultrasound (28) could uncover functional ischemia in our nNOS Ϫ/Ϫ mice during fatiguing stimulation. Nevertheless, even if functional ischemia in nNOS Ϫ/Ϫ mice was apparent during the fatigue protocol, this would presumably have the effect of enhancing the muscle susceptibility to fatigue, rather than reducing it.
We also examined the expression of antioxidant and stressrelated proteins in the uninjured muscles of nNOS Ϫ/Ϫ mice. A recent study reported significantly higher mRNA and protein expression of a number of antioxidant enzymes in the extensor digitorum longus muscles of nNOS Ϫ/Ϫ than wild-type mice (6). We found no difference between nNOS Ϫ/Ϫ mice and wild-type controls in the mRNA expression of any of the antioxidant/cytoprotective proteins examined, although there was a (nonsignificant) trend for increased expression of all three antioxidant enzymes. Our results indicate that the enhanced resistance to fatigue of the TA muscles from nNOS Ϫ/Ϫ mice in the present study cannot be explained by differences in myofiber oxidative capacity, antioxidant or heat shock protein expression, or hemodynamic changes; however, the increase in mRNA expression of MyHC types I and IIx may in part explain the more fatigue-resistant phenotype. The cellular mechanisms underlying this resistance to fatigue remain to be fully elucidated.
We then examined the return of force-producing capacity to regenerating muscles of nNOS Ϫ/Ϫ mice after acute myotoxic injury. We found that although the regenerating muscles of nNOS Ϫ/Ϫ mice had a lower median myofiber CSA than wildtype littermates, there was no difference in muscle mass, the proportion of centrally nucleated fibers in the muscle, or myogenin mRNA expression between the groups. Finally, we found no difference in force production by the regenerating muscle when measured as absolute force (P o ) or normalized force (sP o ), suggesting that the return of force-producing capacity of the injured muscle was unaffected by the absence of nNOS. That nNOS Ϫ/Ϫ mice exhibited no deficit in force production during regeneration may seem difficult to reconcile with the observation that uninjured muscles from nNOS Ϫ/Ϫ mice produced lower absolute forces than their wild-type littermates. This suggests that the absence of nNOS does not affect the force-producing ability of muscles during the early stages of regeneration and myofiber formation but exerts an effect on force production in the later stages of myofiber maturation. The equal force production in regenerating muscles from the two groups is even more difficult to reconcile with the significantly reduced myofiber CSA in the nNOS Ϫ/Ϫ muscles. This raises the possibility that, at least in the early stages of muscle regeneration, morphological indicators such as myofiber CSA do not necessarily correlate with the forceproducing ability of the regenerating muscles. Further studies examining the effect of nNOS on the formation and maturation of myofibers in vivo following notexin injury may elucidate this process more clearly.
Taken together, our data indicate that although NO produced by nNOS plays an important role in muscle repair in chronic conditions such as muscular dystrophy (2, 17, 18, 30, 33, 34) and, indeed, may play a role in some aspects of muscle repair after less severe forms of myotoxic injury, nNOS is not essential to functional recovery after notexin injury. If, as reported previously, NO is necessary for satellite cell activation and muscle repair after injury (1, 8, 9 ), yet genetic deletion of nNOS did not impair regeneration in our study, then the isoform of NOS most important for generating NO during regeneration must therefore be eNOS or iNOS. As any muscle injury (including the notexin model used in the present study) will produce significant inflammation, it seems far more likely that iNOS is the source of NO required for successful regeneration. Indeed, recent studies have suggested that iNOS is the crucial source of NO during repair after acute injury (8, 9) . Further studies examining muscle regeneration in iNOS and eNOS knockout mice may shed light on the relative contribution of each isoform to muscle regeneration after acute injury.
Perspectives and Significance
While previous studies have established a role for NO in muscle regeneration, in the present study we found that nNOS is not essential for early functional regeneration after acute myotoxic injury. These data suggest that another NOS isoform, most probably iNOS, is likely to be responsible for influencing muscle regeneration after acute injury. Studies investigating muscle regeneration in iNOS and eNOS knockout mice may reveal how each isoform contributes to successful muscle fiber regeneration after injury. Furthermore, our results indicate that studies assessing muscle regeneration must not rely on morphological indicators alone, since these markers may not necessarily correlate with the restoration of contractile force.
